Jeggle Helmut Wolfgang
SEC Form 4 insider trading activity
Jeggle Helmut Wolfgang has filed 1 SEC Form 4 filing (2 transaction rows) across 1 company, with disclosures dating back to 2026. 1 of those filings fall inside the rolling window. Most recent filing: Nov 2, 2026.
On the most recent filing, Jeggle Helmut Wolfgang is listed as Director, 10% Owner at Bambusa Therapeutics, Inc. Inside the rolling window, Jeggle Helmut Wolfgang reported 1 open-market purchase totaling $6.0M in BBTX and no open-market sales.
Companies traded
Other insiders at BBTX
Insider Buying
$6.0M
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Jeggle Helmut Wolfgang made?
Jeggle Helmut Wolfgang has filed 1 SEC Form 4 filing (2 transaction rows) across 1 company since 2026.
Which companies does Jeggle Helmut Wolfgang trade?
Jeggle Helmut Wolfgang has filed SEC Form 4 disclosures for 1 company, including BBTX.
When was Jeggle Helmut Wolfgang's most recent SEC Form 4 filing?
Jeggle Helmut Wolfgang's most recent SEC Form 4 filing on Tracefour is dated Nov 2, 2026.
What is Jeggle Helmut Wolfgang's total buy and sell value in the current window?
Inside the rolling retention window, Jeggle Helmut Wolfgang bought $6.0M and sold $0 based on SEC Form 4 filings.
What was Jeggle Helmut Wolfgang's largest disclosed transaction?
The largest disclosed transaction in the current window is a purchase of 375,000 BBTX shares on 2026-11-02, worth $6.0M, per SEC Form 4 filings.